Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?. Biomol Biomed [Internet]. 2022 Jul. 29 [cited 2024 May 4];22(4):660-4. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/6901